This accomplished scietific leader has taken early-stage diagnostics companies from proof-of-concept to FDA-submission readiness, securing patents across oligonucleotide-based detection platforms, microbial diagnostics, and COVID-19 targets, with hands-on involvement in cross-functional tech transfers spanning the US and China (NMPA).

Their track record spans assay development and sample processing consumables, including rapid IVD platforms, with particular depth in infectious disease, oligonucleotide probe design, and cancer biology.

They have built the scientific foundations that early-stage companies need most: wet-lab capabilities from scratch, cross-functional team relationships across engineering, QA, and manufacturing, and the frameworks to translate complex biomarker science into commercially viable, regulatory-ready products.

Holding a PhD in Biochemistry with postdoctoral work at leading US universities, and a peer-reviewed publication record, they have served in Director and R&D leadership roles at multiple venture-backed diagnostics startups, driving products from bench to pre-submission while pitching technical capabilities directly to strategic investors and venture groups.

Available for Director/VP of R&D, Assay Development, or Translational Science roles. Greater Boston-based, open to remote and select relocation.

Download Candidate Profile